| ATC kode | |
| J | Midler mod infektionssygdomme til systemisk brug |
| J01 | Antibakterielle midler til systemisk brug |
| J01A | Tetracycliner |
| J01AA | Tetracycliner |
| J01AA01 | Demeclocyclin |
| J01AA02 | Doxycyclin |
| J01AA03 | Chlortetracyclin |
| J01AA04 | Lymecyclin |
| J01AA05 | Metacyclin |
| J01AA06 | Oxytetracyclin |
| J01AA07 | Tetracyclin |
| J01AA08 | Minocyclin |
| J01AA09 | Rolitetracyclin |
| J01AA10 | Penimepicyclin |
| J01AA11 | Clomocyclin |
| J01AA12 | Tigecyclin |
| J01AA13 | Eravacyclin |
| J01AA14 | Sarecyclin |
| J01AA15 | Omadacyclin |
| J01AA20 | Kombinationer af tetracycliner |
| J01AA56 | Oxytetracyclin, kombinationer |
| J01B | Amphenicoler |
| J01BA | Amphenicoler |
| J01BA01 | Chloramphenicol |
| J01BA02 | Thiamphenicol |
| J01BA52 | Thiamphenicol, komb. |
| J01C | Beta-lactam antibakterika, penicilliner |
| J01CA | Penicilliner med udvidet spektrum |
| J01CA01 | Ampicillin |
| J01CA02 | Pivampicillin |
| J01CA03 | Carbenicillin |
| J01CA04 | Amoxicillin |
| J01CA05 | Carindacillin |
| J01CA06 | Bacampicillin |
| J01CA07 | Epicillin |
| J01CA08 | Pivmecillinam |
| J01CA09 | Azlocillin |
| J01CA10 | Mezlocillin |
| J01CA11 | Mecillinam |
| J01CA12 | Piperacillin |
| J01CA13 | Ticarcillin |
| J01CA14 | Metampicillin |
| J01CA15 | Talampicillin |
| J01CA16 | Sulbenicillin |
| J01CA17 | Temocillin |
| J01CA18 | Hetacillin |
| J01CA19 | Aspoxicillin |
| J01CA20 | Kombinationer |
| J01CA51 | Ampicillin, kombinationer |
| J01CE | Beta-lactamase sensitive penicilliner |
| J01CE01 | Benzylpenicillin |
| J01CE02 | Phenoxymethylpenicillin |
| J01CE03 | Propicillin |
| J01CE04 | Azidocillin |
| J01CE05 | Pheneticillin |
| J01CE06 | Penamecillin |
| J01CE07 | Clometocillin |
| J01CE08 | Benzathin benzylpenicillin |
| J01CE09 | Procain penicillin |
| J01CE10 | Benzathin phenoxymethylpenicillin |
| J01CE30 | Kombinationer |
| J01CF | Beta-lactamase resistente penicilliner |
| J01CF01 | Dicloxacillin |
| J01CF02 | Cloxacillin |
| J01CF03 | Methicillin |
| J01CF04 | Oxacillin |
| J01CF05 | Flucloxacillin |
| J01CF06 | Nafcillin |
| J01CG | Beta-lactamase inhibitorer |
| J01CG01 | Sulbactam |
| J01CG02 | Tazobactam |
| J01CR | Komb. af penicilliner, incl. beta-lactamase inhib. |
| J01CR01 | Ampicillin og beta-lactamaseinhibitor |
| J01CR02 | Amoxicillin og beta-lactamaseinhibitor |
| J01CR03 | Ticarcillin og beta-lactamaseinhibitor |
| J01CR04 | Sultamicillin og enzym-inhibitor |
| J01CR05 | Piperacillin og beta-lactamaseinhibitor |
| J01CR50 | Kombinationer af penicilliner |
| J01D | Andre beta-lactam antibakterika |
| J01DB | Cephalosporiner, 1. generation |
| J01DB01 | Cefalexin |
| J01DB02 | Cefaloridin |
| J01DB03 | Cefalotin |
| J01DB04 | Cefazolin |
| J01DB05 | Cefadroxil |
| J01DB06 | Cefazedon |
| J01DB07 | Cefatrizin |
| J01DB08 | Cefapirin |
| J01DB09 | Cefradin |
| J01DB10 | Cefacetril |
| J01DB11 | Cefroxadin |
| J01DB12 | Ceftezol |
| J01DC | Cephalosporiner, 2. generation |
| J01DC01 | Cefoxitin |
| J01DC02 | Cefuroxim |
| J01DC03 | Cefamandol |
| J01DC04 | Cefaclor |
| J01DC05 | Cefotetan |
| J01DC06 | Cefonicid |
| J01DC07 | Cefotiam |
| J01DC08 | Loracarbef |
| J01DC09 | Cefmetazol |
| J01DC10 | Cefprozil |
| J01DC11 | Ceforanid |
| J01DC12 | Cefminox |
| J01DC13 | Cefbuperazon |
| J01DC14 | Flomoxef |
| J01DC52 | Cefuroxim og beta-lactamaseinhibitor |
| J01DD | Cephalosporiner, 3. generation |
| J01DD01 | Cefotaxim |
| J01DD02 | Ceftazidim |
| J01DD03 | Cefsulodin |
| J01DD04 | Ceftriaxon |
| J01DD05 | Cefmenoxim |
| J01DD06 | Latamoxef |
| J01DD07 | Ceftizoxim |
| J01DD08 | Cefixim |
| J01DD09 | Cefodizim |
| J01DD10 | Cefetamet |
| J01DD11 | Cefpiramid |
| J01DD12 | Cefoperazon |
| J01DD13 | Cefpodoxim |
| J01DD14 | Ceftibuten |
| J01DD15 | Cefdinir |
| J01DD16 | Cefditoren |
| J01DD17 | Cefcapen |
| J01DD18 | Cefteram |
| J01DD51 | Cefotaxime and beta-lactamase inhibitor |
| J01DD52 | Ceftazidime og beta-lactamaseinhibitor |
| J01DD54 | Ceftriaxon, kombinationer |
| J01DD58 | Cefixim og beta-lactamasehæmmer |
| J01DD62 | Cefoperazone og beta-lactamaseinhibitor |
| J01DD63 | Ceftriaxon og beta-lactamaseinhibitor |
| J01DD64 | Cefpodoxim og beta-lactamaseinhibitor |
| J01DE | Cephalosporiner, 4. generation |
| J01DE01 | Cefepim |
| J01DE02 | Cefpirom |
| J01DE03 | Cefozopran |
| J01DE51 | Cefepim og beta-lactamaseinhibitor |
| J01DF | Monobactamer |
| J01DF01 | Aztreonam |
| J01DF02 | Carumonam |
| J01DF51 | Aztreonam og beta-lactamase hæmmer |
| J01DH | Carbapenemer |
| J01DH02 | Meropenem |
| J01DH03 | Ertapenem |
| J01DH04 | Doripenem |
| J01DH05 | Biapenem |
| J01DH06 | Tebipenem pivoxil |
| J01DH51 | Imipenem og cilastatin |
| J01DH52 | Meropenem og vaborbactam |
| J01DH55 | Panipenem og betamipron |
| J01DH56 | Imipenem, cilastatin og relebactam |
| J01DI | Andre cephalosporiner og penemer |
| J01DI01 | Ceftobiprolmedocaril |
| J01DI02 | Ceftarolin fosamil |
| J01DI03 | Faropenem |
| J01DI04 | Cefiderocol |
| J01DI54 | Ceftolozane og beta-lactamaseinhibitor |
| J01E | Sulfonamider og trimethoprim |
| J01EA | Trimethoprim og derivater |
| J01EA01 | Trimethoprim |
| J01EA02 | Brodimoprim |
| J01EA03 | Iclaprim |
| J01EB | Sulfonamider med kort virkningstid |
| J01EB01 | Sulfaisodimidin |
| J01EB02 | Sulfamethizol |
| J01EB03 | Sulfadimidin |
| J01EB04 | Sulfapyridin |
| J01EB05 | Sulfafurazol |
| J01EB06 | Sulfanilamid |
| J01EB07 | Sulfathiazol |
| J01EB08 | Sulfathiourea |
| J01EB20 | Kombinationer |
| J01EC | Sulfonamider med middellang virkningstid |
| J01EC01 | Sulfamethoxazol |
| J01EC02 | Sulfadiazin |
| J01EC03 | Sulfamoxol |
| J01EC20 | Kombinationer |
| J01ED | Sulfonamider med lang virkningstid |
| J01ED01 | Sulfadimethoxin |
| J01ED02 | Sulfalen |
| J01ED03 | Sulfamethomidin |
| J01ED04 | Sulfamethoxydiazin |
| J01ED05 | Sulfamethoxypyridazin |
| J01ED06 | Sulfaperin |
| J01ED07 | Sulfamerazin |
| J01ED08 | Sulfaphenazol |
| J01ED09 | Sulfamazon |
| J01ED20 | Kombinationer |
| J01EE | Sulfonamid og trimethoprim incl. derivater i komb. |
| J01EE01 | Sulfamethoxazol og trimethoprim |
| J01EE02 | Sulfadiazin og trimethoprim |
| J01EE03 | Sulfametrol og trimethoprim |
| J01EE04 | Sulfamoxol og trimethoprim |
| J01EE05 | Sulfadimidin og trimethoprim |
| J01EE06 | Sulfadiazin og tetroxoprim |
| J01EE07 | Sulfamerazin og trimethoprim |
| J01F | Macrolider, lincosamider og streptograminer |
| J01FA | Macrolider |
| J01FA01 | Erythromycin |
| J01FA02 | Spiramycin |
| J01FA03 | Midecamycin |
| J01FA05 | Oleandomycin |
| J01FA06 | Roxithromycin |
| J01FA07 | Josamycin |
| J01FA08 | Troleandomycin |
| J01FA09 | Clarithromycin |
| J01FA10 | Azithromycin |
| J01FA11 | Miocamycin |
| J01FA12 | Rokitamycin |
| J01FA13 | Dirithromycin |
| J01FA14 | Flurithromycin |
| J01FA15 | Telithromycin |
| J01FA16 | Solithromycin |
| J01FF | Lincosamider |
| J01FF01 | Clindamycin |
| J01FF02 | Lincomycin |
| J01FG | Streptograminer |
| J01FG01 | Pristinamycin |
| J01FG02 | Quinupristin/dalfopristin |
| J01G | Aminoglycosid antibakterika |
| J01GA | Streptomyciner |
| J01GA01 | Streptomycin |
| J01GA02 | Streptoduocin |
| J01GB | Andre aminoglycosider |
| J01GB01 | Tobramycin |
| J01GB03 | Gentamicin |
| J01GB04 | Kanamycin |
| J01GB05 | Neomycin |
| J01GB06 | Amikacin |
| J01GB07 | Netilmicin |
| J01GB08 | Sisomicin |
| J01GB09 | Dibekacin |
| J01GB10 | Ribostamycin |
| J01GB11 | Isepamicin |
| J01GB12 | Arbekacin |
| J01GB13 | Bekanamycin |
| J01GB14 | Plazomicin |
| J01M | Quinolon antibakterika |
| J01MA | Fluorochinoloner |
| J01MA01 | Ofloxacin |
| J01MA02 | Ciprofloxacin |
| J01MA03 | Pefloxacin |
| J01MA04 | Enoxacin |
| J01MA05 | Temafloxacin |
| J01MA06 | Norfloxacin |
| J01MA07 | Lomefloxacin |
| J01MA08 | Fleroxacin |
| J01MA09 | Sparfloxacin |
| J01MA10 | Rufloxacin |
| J01MA11 | Grepafloxacin |
| J01MA12 | Levofloxacin |
| J01MA13 | Trovafloxacin |
| J01MA14 | Moxifloxacin |
| J01MA15 | Gemifloxacin |
| J01MA16 | Gatifloxacin |
| J01MA17 | Prulifloxacin |
| J01MA18 | Pazufloxacin |
| J01MA19 | Garenoxacin |
| J01MA21 | Sitafloxacin |
| J01MA22 | Tosufloxacin |
| J01MA23 | Delafloxacin |
| J01MA24 | Levonadifloxacin |
| J01MA25 | Lascufloxacin |
| J01MB | Andre quinoloner |
| J01MB01 | Rosoxacin |
| J01MB02 | Nalidixinsyre |
| J01MB03 | Piromidinsyre |
| J01MB04 | Pipemidinsyre |
| J01MB05 | Oxolinsyre |
| J01MB06 | Cinoxacin |
| J01MB07 | Flumequin |
| J01MB08 | Nemonoxacin |
| J01R | Kombinationer af antibakterika |
| J01RA | Kombinationer af antibakterika |
| J01RA01 | Penicilliner, komb. med andre antibakterika |
| J01RA02 | Sulfonamider, komb. med andre antibakterika excl. trimethoprim |
| J01RA03 | Cefuroxim og metronidazol |
| J01RA04 | Spiramycin og metronidazol |
| J01RA05 | Levofloxacin og ornidazol |
| J01RA06 | Cefepim og amikacin |
| J01RA07 | Azithromycin, fluconazol og secnidazol |
| J01RA08 | Tetracyclin og oleandomycin |
| J01RA09 | Ofloxacin og ornidazol |
| J01RA10 | Ciprofloxacin og metronidazol |
| J01RA11 | Ciprofloxacin og tinidazol |
| J01RA12 | Ciprofloxacin og ornidazol |
| J01RA13 | Norfloxacin og tinidazol |
| J01RA14 | Norfloxacin og metronidazol |
| J01RA15 | Cefixim og ornidazol |
| J01RA16 | Cefixim og azithromycin |
| J01RA17 | Ofloxacin og nitazoxanid |
| J01RA18 | Ofloxacin og tinidazol |
| J01RA19 | Tetracyclin og nystatin |
| J01X | Andre antibakterika |
| J01XA | Glycopeptid antibakterika |
| J01XA01 | Vancomycin |
| J01XA02 | Teicoplanin |
| J01XA03 | Telavancin |
| J01XA04 | Dalbavancin |
| J01XA05 | Oritavancin |
| J01XB | Polymyxiner |
| J01XB01 | Colistin |
| J01XB02 | Polymyxin b |
| J01XC | Steroid antibakterika |
| J01XC01 | Fusidinsyre |
| J01XD | Imidazol-derivater |
| J01XD01 | Metronidazol |
| J01XD02 | Tinidazol |
| J01XD03 | Ornidazol |
| J01XE | Nitrofuran-derivater |
| J01XE01 | Nitrofurantoin |
| J01XE02 | Nifurtoinol |
| J01XE03 | Furazidin |
| J01XE51 | Nitrofurantoin, kombinationer |
| J01XX | Andre antibakterika |
| J01XX01 | Fosfomycin |
| J01XX02 | Xibornol |
| J01XX03 | Clofoctol |
| J01XX04 | Spectinomycin |
| J01XX05 | Methenamin |
| J01XX06 | Mandelsyre |
| J01XX07 | Nitroxolin |
| J01XX08 | Linezolid |
| J01XX09 | Daptomycin |
| J01XX10 | Bacitracin |
| J01XX11 | Tedizolid |
| J01XX12 | Lefamulin |
| J01XX13 | Gepotidacin |
| J02 | Antimykotika til systemisk brug |
| J02A | Antimykotika til systemisk brug |
| J02AA | Antibiotika |
| J02AA01 | Amphotericin |
| J02AA02 | Hachimycin |
| J02AB | Imidazol-derivater |
| J02AB01 | Miconazol |
| J02AB02 | Ketoconazol |
| J02AC | Triazol- og tetrazolderivater |
| J02AC01 | Fluconazol |
| J02AC02 | Itraconazol |
| J02AC03 | Voriconazol |
| J02AC04 | Posaconazol |
| J02AC05 | Isavuconazol |
| J02AC06 | Oteseconazol |
| J02AX | Andre antimykotika til systemisk brug |
| J02AX01 | Flucytosin |
| J02AX04 | Caspofungin |
| J02AX05 | Micafungin |
| J02AX06 | Anidulafungin |
| J02AX07 | Ibrexafungerp |
| J02AX08 | Rezafunginacetat |
| J04 | Antimycobacterica |
| J04A | Stoffer til behandling af tuberculose |
| J04AA | Aminosalicylsyre og derivater |
| J04AA01 | Aminosalicylsyre |
| J04AA02 | Natriumaminosalicylat |
| J04AA03 | Calciumaminosalicylat |
| J04AB | Antibiotika |
| J04AB01 | Cycloserin |
| J04AB02 | Rifampicin |
| J04AB03 | Rifamycin |
| J04AB04 | Rifabutin |
| J04AB05 | Rifapentin |
| J04AB06 | Enviomycin |
| J04AB30 | Capreomycin |
| J04AC | Hydrazider |
| J04AC01 | Isoniazid |
| J04AC02 | Ftivazid |
| J04AC51 | Isoniazid, kombinationer |
| J04AD | Thiocarbamid-derivater |
| J04AD01 | Protionamid |
| J04AD02 | Tiocarlid |
| J04AD03 | Ethionamid |
| J04AK | Andre stoffer til behandling af tuberculose |
| J04AK01 | Pyrazinamid |
| J04AK02 | Ethambutol |
| J04AK03 | Terizidon |
| J04AK04 | Morinamid |
| J04AK05 | Bedaquilin |
| J04AK06 | Delamanid |
| J04AK07 | Thioacetazon |
| J04AK08 | Pretomanid |
| J04AM | Komb. af stoffer til behandling af tuberculose |
| J04AM01 | Streptomycin og isoniazid |
| J04AM02 | Rifampicin og isoniazid |
| J04AM03 | Ethambutol og isoniazid |
| J04AM04 | Thioacetazon og isoniazid |
| J04AM05 | Rifampicin, pyrazinamid og isoniazid |
| J04AM06 | Rifampicin, pyrazinamid, ethambutol og isoniazid |
| J04AM07 | Rifampicin, ethambutol og isoniazid |
| J04AM08 | Isoniazid, sulfamethoxazol og trimethoprim |
| J04AM09 | Pyrazinamid, ethambutol, isoniazid og lomefloxacin |
| J04AM10 | Pyrazinamid, ethambutol, protionamid og lomefloxacin |
| J04AM11 | Rifabutin, pyrazinamid og protionamid |
| J04AM12 | Rifampicin, pyrazinamid, isoniazid og levofloxacin |
| J04B | Midler til behandling af lepra |
| J04BA | Midler til behandling af lepra |
| J04BA01 | Clofazimin |
| J04BA02 | Dapson |
| J04BA03 | Aldesulfonnatrium |
| J04BA50 | Dapson og rifampicin |
| J04BA51 | Dapson, rifampicin og clofazimin |
| J05 | Antivirale midler til systemisk brug |
| J05A | Direkte virkende antivirale midler |
| J05AA | Thiosemicarbazoner |
| J05AA01 | Metisazon |
| J05AB | Nucleosider og nucleotider excl. revers transcriptase-hæmmere |
| J05AB01 | Aciclovir |
| J05AB02 | Idoxuridin |
| J05AB03 | Vidarabin |
| J05AB06 | Ganciclovir |
| J05AB09 | Famciclovir |
| J05AB11 | Valaciclovir |
| J05AB12 | Cidofovir |
| J05AB13 | Penciclovir |
| J05AB14 | Valganciclovir |
| J05AB15 | Brivudin |
| J05AB16 | Remdesivir |
| J05AB17 | Brincidofovir |
| J05AB18 | Molnupiravir |
| J05AC | Cykliske aminer |
| J05AC02 | Rimantadin |
| J05AC03 | Tromantadin |
| J05AD | Phosphonsyre-derivater |
| J05AD01 | Foscarnet |
| J05AD02 | Fosfonet |
| J05AE | Protease inhibitorer |
| J05AE01 | Saquinavir |
| J05AE02 | Indinavir |
| J05AE03 | Ritonavir |
| J05AE04 | Nelfinavir |
| J05AE05 | Amprenavir |
| J05AE07 | Fosamprenavir |
| J05AE08 | Atazanavir |
| J05AE09 | Tipranavir |
| J05AE10 | Darunavir |
| J05AE16 | Ensitrelvir |
| J05AE30 | Nirmatrelvir og ritonavir |
| J05AF | Nucleosid og nucleotid revers transcriptase-hæmmere |
| J05AF01 | Zidovudin |
| J05AF02 | Didanosin |
| J05AF03 | Zalcitabin |
| J05AF04 | Stavudin |
| J05AF05 | Lamivudin |
| J05AF06 | Abacavir |
| J05AF07 | Tenofovir disoproxil |
| J05AF08 | Adefovir dipivoxil |
| J05AF09 | Emtricitabin |
| J05AF10 | Entecavir |
| J05AF11 | Telbivudin |
| J05AF12 | Clevudin |
| J05AF13 | Tenofovir alafenamid |
| J05AG | Non-nucleosid revers transcriptase-hæmmere |
| J05AG01 | Nevirapin |
| J05AG02 | Delavirdin |
| J05AG03 | Efavirenz |
| J05AG04 | Etravirin |
| J05AG05 | Rilpivirin |
| J05AG06 | Doravirin |
| J05AG07 | Elsulfavirin |
| J05AH | Neuraminidase-inhibitorer |
| J05AH01 | Zanamivir |
| J05AH02 | Oseltamivir |
| J05AH03 | Peramivir |
| J05AH04 | Laninamivir |
| J05AJ | Integrasehæmmere |
| J05AJ01 | Raltegravir |
| J05AJ02 | Elvitegravir |
| J05AJ03 | Dolutegravir |
| J05AJ04 | Cabotegravir |
| J05AP | Antivirale midler til behandling af hcv-infektioner |
| J05AP01 | Ribavirin |
| J05AP02 | Telaprevir |
| J05AP03 | Boceprevir |
| J05AP04 | Faldaprevir |
| J05AP05 | Simeprevir |
| J05AP06 | Asunaprevir |
| J05AP07 | Daclatasvir |
| J05AP08 | Sofosbuvir |
| J05AP09 | Dasabuvir |
| J05AP10 | Elbasvir |
| J05AP11 | Grazoprevir |
| J05AP12 | Coblopasvir |
| J05AP13 | Ravidasvir |
| J05AP14 | Narlaprevir |
| J05AP51 | Sofosbuvir og ledipasvir |
| J05AP52 | Dasabuvir, ombitasvir, paritaprevir og ritonavir |
| J05AP53 | Ombitasvir, paritaprevir og ritonavir |
| J05AP54 | Elbasvir og grazoprevir |
| J05AP55 | Sofosbuvir og velpatasvir |
| J05AP56 | Sofosbuvir, velpatasvir og voxilaprevir |
| J05AP57 | Glecaprevir og pibrentasvir |
| J05AP58 | Daclatasvir, asunaprevir og beclabuvir |
| J05AR | Antivirale midler til behandling af hiv-infektioner, komb. |
| J05AR01 | Zidovudin og lamivudin |
| J05AR02 | Lamivudin og abacavir |
| J05AR03 | Tenofovirdisoproxil og emtricitabin |
| J05AR04 | Zidovudin, lamivudin og abacavir |
| J05AR05 | Zidovudin, lamivudin og nevirapin |
| J05AR06 | Emtricitabin,tenofovirdisoproxil og efavirenz |
| J05AR07 | Stavudin, lamivudin og nevirapin |
| J05AR08 | Emtricitabin, tenofovirdisoproxil og rilpivirin |
| J05AR09 | Emtricitabin, tenofovirdisoproxil, elvitegravir og cobicistat |
| J05AR10 | Lopinavir og ritonavir |
| J05AR11 | Lamivudin, tenofovir disoproxil og efavirenz |
| J05AR12 | Lamivudin og tenofovirdisoproxil |
| J05AR13 | Lamivudin, abacavir og dolutegravir |
| J05AR14 | Darunavir og cobicistat |
| J05AR15 | Atazanavir og cobicistat |
| J05AR16 | Lamivudin og raltegravir |
| J05AR17 | Emtricitabin og tenofovir alafenamid |
| J05AR18 | Emtricitabin, tenofovir alafenamid, elvitegravir og cobicistat |
| J05AR19 | Emtricitabin, tenofovir alafenamid og rilpivirin |
| J05AR20 | Emtricitabin, tenofovir alafenamid og bictegravir |
| J05AR21 | Dolutegravir og rilpivirin |
| J05AR22 | Emtricitabin, tenofovir alafenamid, darunavir og cobicistat |
| J05AR23 | Atazanavir og ritonavir |
| J05AR24 | Lamivudin, tenofovirdisoproxil og doravirin |
| J05AR25 | Lamivudin og dolutegravir |
| J05AR26 | Darunavir og ritonavir |
| J05AR27 | Lamivudin, tenofovirdisoproxil og dolutegravir |
| J05AR28 | Stavudin og lamivudin |
| J05AR29 | Emtricitabin, tenofovir alafenamid og dolutegravir |
| J05AX | Andre antivirale midler |
| J05AX01 | Moroxydin |
| J05AX02 | Lysozym |
| J05AX05 | Inosin pranobex |
| J05AX06 | Pleconaril |
| J05AX07 | Enfuvirtid |
| J05AX09 | Maraviroc |
| J05AX10 | Maribavir |
| J05AX13 | Umifenovir |
| J05AX17 | Enisamiumiodid |
| J05AX18 | Letermovir |
| J05AX19 | Tiloron |
| J05AX21 | Pentandisyreimidazolylethanamid |
| J05AX23 | Ibalizumab |
| J05AX24 | Tecovirimat |
| J05AX25 | Baloxavirmarboxil |
| J05AX26 | Amenamevir |
| J05AX27 | Favipiravir |
| J05AX28 | Bulevirtid |
| J05AX29 | Fostemsavir |
| J05AX31 | Lenacapavir |
| J05AX32 | Riamilovir |
| J05AX33 | Labuvirtid |
| J06 | Immunsera og immunoglobuliner |
| J06A | Immunsera |
| J06AA | Immunsera |
| J06AA01 | Difteri antitoxin |
| J06AA02 | Tetanus antitoxin |
| J06AA03 | Slangegift antiserum |
| J06AA04 | Botulinum antitoxin |
| J06AA05 | Gas-gangræn sera |
| J06AA06 | Rabies serum |
| J06B | Immunoglobuliner |
| J06BA | Immunoglobuliner, normal human |
| J06BA01 | Immunoglobuliner, normal human til extravasc. brug |
| J06BA02 | Immunoglobuliner, normal human til intravasc. brug |
| J06BB | Specifikke immunoglobuliner |
| J06BB01 | Anti-d (rh) immunoglobulin |
| J06BB02 | Tetanus immunoglobulin |
| J06BB03 | Varicella/zoster immunoglobulin |
| J06BB04 | Hepatitis b immunoglobulin |
| J06BB05 | Rabies immunoglobulin |
| J06BB06 | Rubella immunoglobulin |
| J06BB07 | Vaccinia immunoglobulin |
| J06BB08 | Staphylococcus immunoglobulin |
| J06BB09 | Cytomegalovirus immunoglobulin |
| J06BB10 | Difteri immunoglobulin |
| J06BB11 | Hepatitis a immunoglobulin |
| J06BB12 | Encephalitis, tick borne immunoglobulin |
| J06BB13 | Pertussis immunoglobulin |
| J06BB14 | Morbilli immunoglobulin |
| J06BB15 | Parotitis immunoglobulin |
| J06BB19 | Anthrax immunoglobulin |
| J06BB30 | Specifikke immunoglobuliner, komb. |
| J06BC | Antibakterielle monoklonale antistoffer |
| J06BC01 | Nebacumab |
| J06BC02 | Raxibacumab |
| J06BC03 | Bezlotoxumab |
| J06BC04 | Obiltoxaximab |
| J06BD | Antivirale monoklonale antistoffer |
| J06BD01 | Palivizumab |
| J06BD02 | Motavizumab |
| J06BD03 | Tixagevimab og cilgavimab |
| J06BD04 | Ansuvimab |
| J06BD05 | Sotrovimab |
| J06BD06 | Regdanvimab |
| J06BD07 | Casirivimab og imdevimab |
| J06BD08 | Nirsevimab |
| J06BD09 | Sipavibart |
| J07 | Vacciner |
| J07A | Bacterielle vacciner |
| J07AC | Anthrax vacciner |
| J07AC01 | Anthrax antigen |
| J07AD | Brucellose vacciner |
| J07AD01 | Brucella antigen |
| J07AE | Cholera vacciner |
| J07AE01 | Cholera, inaktiveret, hele celler |
| J07AE02 | Cholera, levende attenueret |
| J07AE51 | Cholera,komb. med typhoid vac., inakt.,hele celler |
| J07AF | Difteri vacciner |
| J07AF01 | Difteri toxoid |
| J07AG | Haemophilus influenzae b vacciner |
| J07AG01 | Haemophilus influenzae b, purif. antig. conjugated |
| J07AG51 | Haemophilus influenzae b, komb. m. toxoider |
| J07AG52 | Haemophilus influenzae b, komb.m. pertussis og toxoider |
| J07AG53 | Haemophilus influenzae b, komb. med meningococcus c, conjugated |
| J07AG54 | Haemophilus influenza b, komb. med meningococcus c,y, konjugeret |
| J07AH | Meningokok vacciner |
| J07AH01 | Meningococcus a, renset polysacc. antigen |
| J07AH02 | Andre meningococcal monov.,renset polysac.antigen |
| J07AH03 | Meningococcus a,c, bivalent renset polysacc. antigen |
| J07AH04 | Meningococcus a,c,y,w-135, tetraval. renset polysacc.antigen |
| J07AH05 | Andre meningococcal polyv. renset polysacc.antigen |
| J07AH06 | Meningococcus b, outer membrane vesicle vaccine |
| J07AH07 | Meningococcus c, renset polysacc. antigen konj. |
| J07AH08 | Meningococcus a,c,y,w-135, tetravalent renset polysacc. antigen konj. |
| J07AH09 | Meningococcus b, multikomponent vaccine |
| J07AH10 | Meningococcus a, renset polysacc. antigen konj. |
| J07AH11 | Meningococ. a,b,c,y,w-135, pentaval. rens. polysacc.antig. konj. & fakt. |
| J07AJ | Pertussis vacciner |
| J07AJ01 | Pertussis, inaktiveret, hele celler |
| J07AJ02 | Pertussis, renset antigen |
| J07AJ51 | Pertussis, inakt., hele celler, komb. med toxoider |
| J07AJ52 | Pertusiss, renset antigen, komb. med toxoider |
| J07AK | Pest vacciner |
| J07AK01 | Pest, inaktiveret, hele celler |
| J07AL | Pneumokok vacciner |
| J07AL01 | Pneumococcus, renset polysacc. antigen |
| J07AL02 | Pneumococcus, renset polysacc. antigen konj. |
| J07AL52 | Pneumococcus, renset polysacc. antigen og haemophillus influenzae, konj. |
| J07AM | Tetanus vacciner |
| J07AM01 | Tetanus toxoid |
| J07AM51 | Tetanus toxoid, komb. med difteri toxoid |
| J07AM52 | Tetanus toxoid, komb. med tetanus immunoglobulin |
| J07AN | Tuberculose vacciner |
| J07AN01 | Tuberculose, levende attenueret |
| J07AP | Tyfus vacciner |
| J07AP01 | Tyfus, oral, levende attenueret |
| J07AP02 | Tyfus, inaktiveret, hele celler |
| J07AP03 | Tyfus, renset polysaccharid antigen |
| J07AP10 | Tyfus, kombinationer med paratyfus typer |
| J07AR | Typhus exanthematicus vacciner |
| J07AR01 | Typhus exanthematicus, inaktiveret, hele celler |
| J07AX | Andre bacterielle vacciner |
| J07AX01 | Leptospira vacciner |
| J07B | Virale vacciner |
| J07BA | Encephalitis vacciner |
| J07BA01 | Encephalitis, tick borne, inaktiveret, hele virus |
| J07BA02 | Encephalitis, japansk, inaktiveret, hele virus |
| J07BA03 | Encephalitis, japansk, levende svækket |
| J07BB | Influenza vacciner |
| J07BB01 | Influenza, inaktiveret, hele virus |
| J07BB02 | Influenza, renset antigen |
| J07BB03 | Influenza, levende svækket |
| J07BB04 | Influenza, viruslignende partikler |
| J07BB05 | Influenza, rna-baseret vaccine |
| J07BC | Hepatitis vacciner |
| J07BC01 | Hepatitis b, renset antigen |
| J07BC02 | Hepatitis a, inaktiveret, hel virus |
| J07BC20 | Hepatitis vacciner, kombinationer |
| J07BD | Mæslingevacciner |
| J07BD01 | Mæslinger, levende attenueret |
| J07BD51 | Mæslinger, komb. m. fåresyge, levende attenueret |
| J07BD52 | Mæslinger, komb. m. fåresyge og rubella, levende attenueret |
| J07BD53 | Mæslinger, komb. m. rubella, levende attenueret |
| J07BD54 | Mæslinger, komb. med fåresyge, rubella og varicella, levende attenueret |
| J07BE | Fåresygevacciner |
| J07BE01 | Fåresyge, levende attenueret |
| J07BF | Poliomyelitis vacciner |
| J07BF01 | Poliomyelitis oral, monovalent, levende attenueret |
| J07BF02 | Poliomyelitis oral, trivalent, levende attenueret |
| J07BF03 | Poliomyelitis, trivalent, inaktiveret, hele virus |
| J07BF04 | Poliomyelitis oral, bivalent, levende attenueret |
| J07BG | Rabies vacciner |
| J07BG01 | Rabies, inaktiveret, hele virus |
| J07BH | Rota virus diarrhea vacciner |
| J07BH01 | Rota virus, levende attenueret |
| J07BH02 | Rota virus, pentavalent, levende, reassorted |
| J07BJ | Rubella vacciner |
| J07BJ01 | Rubella, levende attenueret |
| J07BJ51 | Rubella, komb. m. fåresyge, levende attenueret |
| J07BK | Varicella zoster vacciner |
| J07BK01 | Varicella, levende attenueret |
| J07BK02 | Zoster virus, levende attenueret |
| J07BK03 | Zoster, renset antigen |
| J07BL | Gul feber vacciner |
| J07BL01 | Gul feber, levende attenueret |
| J07BM | Papillomavirus-vacciner |
| J07BM01 | Papillomavirus (human type 6, 11, 16, 18) |
| J07BM02 | Papillomavirus (human type 16, 18) |
| J07BM03 | Papillomavirus (human type 6, 11, 16, 18, 31, 33, 45, 52,58) |
| J07BN | Covid-19 vacciner |
| J07BN01 | Covid-19, rna-baseret vaccine |
| J07BN02 | Covid-19, virusvektor, non-replikerende |
| J07BN03 | Covid-19, inaktiveret virus |
| J07BN04 | Covid-19, protein subunit |
| J07BN05 | Covid-19, viruslignende partikler |
| J07BX | Andre virale vacciner |
| J07BX01 | Koppevaccine og abekoppevaccine |
| J07BX02 | Ebolavirus |
| J07BX04 | Denguefeber vacciner |
| J07BX05 | Respiratorisk syncytialvirus-vacciner |
| J07BX06 | Enterovirus 71 vacciner |
| J07C | Bacterielle og virale vacciner, kombinerede |
| J07CA | Bacterielle og virale vacciner, kombinerede |
| J07CA01 | Difteri-poliomyelitis-tetanus |
| J07CA02 | Difteri-pertussis-poliomyelitis-tetanus |
| J07CA03 | Difteri-rubella-tetanus |
| J07CA04 | Haemophilus influenza b og poliomyelitis |
| J07CA05 | Difteri-hepatitis b-pertussis-tetanus |
| J07CA06 | Difteri-haemophilus influenzae b-pertussis-polio-tetanus |
| J07CA07 | Difteri-hepatitis b-tetanus |
| J07CA08 | Haemophilus influenzae og hepatitis b |
| J07CA09 | Difteri-haemophilus influenzae b-pertussis-polio-tetanus-hepatitis b |
| J07CA10 | Tyfus - hepatitis a |
| J07CA11 | Difteri-haemophilus influenzae b-pertussis-tetanus-hepatitis b |
| J07CA12 | Difteri-pertussis-polio-tetanus-hepatitis b |
| J07CA13 | Diphtherie-haemophilus-influenzae b-pertussis-tetanus-hepatitis b-mening |
| J07X | Andre vacciner |
| J07XA | Parasitære vacciner |
| J07XA01 | Malariavacciner |
